← FDA Drug Approvals (Drugs@FDA)
RITONAVIR
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2020-12-03
Drug application
- FDA Application #
ANDA205801- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RITONAVIR
- Generic name
- Ritonavir
- Active ingredients
- RITONAVIR
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- HIKMA
- First approval
- 2020-12-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown